We are live on ! Find out more
CC

Callan Capital Portfolio holdings

AUM $1.35B
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
+4.59%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$287M
AUM Growth
+$19.1M
Cap. Flow
+$6.36M
Cap. Flow %
2.21%
Top 10 Hldgs %
77.36%
Holding
54
New
4
Increased
19
Reduced
22
Closed
3
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMLP icon
51
Alerian MLP ETF
AMLP
$13.4B
-26,455
Closed -$1.48M
BIV icon
52
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
-12,373
Closed -$1.05M
VGSH icon
53
Vanguard Short-Term Treasury ETF
VGSH
$30.2B
-18,079
Closed -$1.1M

Similar funds

Callan Capital's Q4 2017 Portfolio in Review

As of Q4 2017, Callan Capital held 54 positions worth $287M, up 7.1% from $268M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Callan Capital's Q4 2017 filing shows 4 new, 19 increased, 22 reduced and 3 closed positions. Its largest new stake was Tortoise North American Pipeline ETF: 543,015 shares worth $12.7M. The largest sale was Vanguard Short-Term Corporate Bond ETF, an estimated $2.67M.

By sector, the portfolio is most concentrated in Miscellaneous at 100% of assets, down from 100% a quarter earlier, followed by Technology and Financials.

  • Callan Capital's largest Q4 2017 buy was Tortoise North American Pipeline ETF: 543,015 shares worth $12.7M.
  • Callan Capital added most to State Street DoubleLine Total Return Tactical ETF in Q4 2017, an estimated $1.63M increase.
  • Callan Capital's biggest Q4 2017 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $2.67M.
  • Callan Capital fully exited Alerian MLP ETF in Q4 2017, selling an estimated $1.48M.
  • Callan Capital's ten largest holdings make up 77% of its $287M portfolio in Q4 2017.
  • Callan Capital opened 4 new positions and closed 3 in Q4 2017.
  • Callan Capital's portfolio value rose 7.1% quarter-over-quarter to $287M.

Based on Callan Capital's 13F filing for Q4 2017, filed 13 Feb 2018.